Aqueous extract from the Withania somnifera leaves as a potential anti-neuroinflammatory agent: A mechanistic study

Journal of Neuroinflammation

Volumn 13, Issue 1, 2016, Pages

  Gupta, Muskan ^a   Kaur, Gurcharan ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

Author keywords

Apoptosis; Ashwagandha; Inflammatory cytokines; Microglia; Neuroinflammation; Pro inflammatory mediators

Indexed keywords

ALPHA TUBULIN; AMYLOID BETA PROTEIN; CYCLIN D1; CYCLINE; FLUORESCEIN ISOTHIOCYANATE; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIX METALLOPROTEINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; WITHANIA SOMNIFERA EXTRACT; ANTIINFLAMMATORY AGENT; CYTOKINE; HEAT SHOCK PROTEIN 72; LIPOCORTIN 5; NERVE PROTEIN; PLANT EXTRACT;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; IMMUNOCYTOCHEMISTRY; MICROGLIA; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; WITHANIA SOMNIFERA; ZYMOGRAPHY; ANIMAL; CELL CULTURE; CELL CYCLE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GLIA; METABOLISM; MOUSE; NEWBORN; SIGNAL TRANSDUCTION; WITHANIA; WOUNDS AND INJURIES;

ANIMALS; ANIMALS, NEWBORN; ANNEXIN A5; ANTI-INFLAMMATORY AGENTS; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; HSP72 HEAT-SHOCK PROTEINS; LIPOPOLYSACCHARIDES; MICE; NERVE TISSUE PROTEINS; NEUROGLIA; NF-KAPPA B; PLANT EXTRACTS; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; WITHANIA; WOUNDS AND INJURIES;

EID: 84983049664     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-016-0650-3     Document Type: Article

References (63)

1. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77-98.
2. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol. 2011;11:775-87.
3. Rock RB, Peterson PK. Microglia as a pharmacological target in infectious and inflammatory diseases of the brain. J Neuroimmune Pharmacol. 2006;1:117-26.
4. Glezer I, Simard AR, Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience. 2007;147:867-83.
5. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharm Exp Ther. 2003;304:1-7.
6. Ajmone-Cat MA, Bernardo A, Greco A, Minghetti L. Non-steroidal anti-inflammatory drugs and brain inflammation: effects on microglial functions. Pharmaceuticals. 2010;3:1949-65.
7. Asanuma M, Nishibayashi Asanuma S, Miyazaki I, Kohno M, Ogawa N. Neuroprotective effects of non steroidal anti inflammatory drugs by direct scavenging of nitric oxide radicals. J Neurochem. 2001;76:1895-904.
8. Choi DK, Koppula S, Suk K. Inhibitors of microglial neurotoxicity: focus on natural products. Molecules. 2011;16:1021-43.
9. Li R, Huang YG, Fang D, Le WD. (-) Epigallocatechin gallate inhibits lipopolysaccharide induced microglial activation and protects against inflammation mediated dopaminergic neuronal injury. J Neurosci Res. 2004;78:723-31.
10. Renaud J, Martinoli MG. Resveratrol as a protective molecule for neuroinflammation: a review of mechanisms. Curr Pharm Biotechnol. 2014;15:318-29.
11. Zhong LM, Zong Y, Sun L, Guo JZ, Zhang W, He Y, et al. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PloS One. 2012. doi: 10.1371/journal.pone.0032195.
12. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev. 2000;5:334-46.
13. Uddin Q, Samiulla L, Singh VK, Jamil SS. Phytochemical and pharmacological profile of Withania somnifera Dunal: a review. J Appl Pharm Sci. 2012;2:170-5.
14. Kumar S, Harris RJ, Seal CJ, Okello EJ. An aqueous extract of Withania somnifera root inhibits amyloid β fibril formation in vitro. Phytother Res. 2012;26:113-7.
15. Matsuda H, Murakami T, Kishi A, Yoshikawa M. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem. 2001;9:1499-507.
16. Grover A, Shandilya A, Punetha A, Bisaria VS, Sundar D. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-kB activation suppression by Withania somnifera's key metabolite withaferin A. BMC Genomics. 2010;11 Suppl 4:S25.
17. Kaileh M, Berghe WV, Heyerick A, Horion J, Piette J, Libert C, et al. Withaferin A strongly elicits IkB kinase β hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Bio Chem. 2007;282:4253-64.
18. Min KJ, Choi K, Kwon TK. Withaferin A down-regulates lipopolysaccharide-induced cyclooxygenase-2 expression and PGE2 production through the inhibition of STAT1/3 activation in microglial cells. Int Immunopharmacol. 2011;11:1137-42.
19. Kataria H, Shah N, Kaul SC, Wadhwa R, Kaur G. Water extract of ashwagandha leaves limits proliferation and migration, and induces differentiation in glioma cells. Evid Based Complement Alternat Med. 2011. doi: 10.1093/ecam/nep188.
20. Kataria H, Wadhwa R, Kaul SC, Kaur G. Withania somnifera water extract as a potential candidate for differentiation based therapy of human neuroblastomas. PLoS One. 2013;2013:8.
21. Kataria H, Kumar S, Chaudhary H, Kaur G. Withania somnifera suppresses tumor growth of intracranial allograft of glioma cells. Mol Neurobiol. 2015. doi: 10.1007/s12035-015-9320-1.
22. Kataria H, Wadhwa R, Kaul SC, Kaur G. Water extract from the leaves of Withania somnifera protects RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PloS One. 2012. doi: 10.1371/journal.pone.0037080.
23. Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. J Immunol. 1998;161:2552-60.
24. Cai Z, Hussain MD, Yan LJ. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease. Int J Neurosci. 2014;124:307-21.
25. Saura J, Tusell JM, Serratosa J. High yield isolation of murine microglia by mild trypsinization. Glia. 2003;44:183-9.
26. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989;119:203-10.
27. Stence N, Waite M, Dailey ME. Dynamics of microglial activation: a confocal time lapse analysis in hippocampal slices. Glia. 2001;33:256-66.
28. Gonzalez H, Elgueta D, Montoya A, Pacheco R. Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases. J Neuroimmunol. 2014;274:1-13.
29. Ohsawa K, Imai Y, Kanazawa H, Sasaki Y, Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J Cell Sci. 2000;113:3073-84.
30. Chiurchiu V, Maccarrone M. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15:2605-41.
31. Qian L, Tan KS, Wei SJ, Wu HM, Xu Z, Wilson B, et al. Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J Immunol. 2007;179:1198-209.
32. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J Neurosci. 1993;13:2651-61.
33. RajaSankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease. Neurosci Lett. 2009;454:11-5.
34. Liu Y, Liu W, Song XD, Zuo J. Effect of GRP75/mthsp70/PBP74/mortalin overexpression on intracellular ATP level, mitochondrial membrane potential and ROS accumulation following glucose deprivation in PC12 cells. Mol Cell Biochem. 2005;268:45-51.
35. Xu L, Voloboueva LA, Ouyang Y, Emery JF, Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab. 2009;29:365-74.
36. Dokladny K, Lobb R, Wharton W, Ma TY, Moseley PL. LPS-induced cytokine levels are repressed by elevated expression of HSP70 in rats: possible role of NF-kB. Cell Stress Chaperon. 2010;15:153-63.
37. Nam KN, Son MS, Park JH, Lee EH. Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-kB: neuroprotective implications. Neuropharmacology. 2008;55:819-25.
38. McCoy MK, Martinez TN, Ruhn KA, Szymkowski DE, Smith CG, Botterman BR, et al. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci. 2006;26:9365-75.
39. Teismann P, Ferger B. Inhibition of the cyclooxygenase isoenzymes COX 1 and COX 2 provide neuroprotection in the MPTP mouse model of Parkinson's disease. Synapse. 2001;39:167-74.
40. Wang T, Qin L, Liu B, Liu Y, Wilson B, Eling TE, et al. Role of reactive oxygen species in LPS induced production of prostaglandin E2 in microglia. J Neurochem. 2004;88:939-47.
41. Lull ME, Block ML. Microglial activation and chronic neurodegeneration. Neurotherapeutics. 2010;7:354-65.
42. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol. 1998;85:1-10.
43. Oh JH, Lee TJ, Park JW, Kwon TK. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kB in RAW 264.7 cells. Eur J Pharmacol. 2008;599:11-7.
44. Leiro J, Arranz JA, Yanez M, Ubeira FM, Sanmartin ML, Orallo F. Expression profiles of genes involved in the mouse nuclear factor-kappa B signal transduction pathway are modulated by mangiferin. Int Immunopharmacol. 2004;4:763-78.
45. Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, et al. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV-2 microglia. Int Immunopharmacol. 2007;7:1092-101.
46. Sivamani S, Joseph B, Kar B. Anti-inflammatory activity of Withania somnifera leaf extract in stainless steel implant induced inflammation in adult zebrafish. J Genet Eng Biotechn. 2014;12:1-6.
47. Maitra R, Porter MA, Huang S, Gilmour BP. Inhibition of NFkappaB by the natural product Withaferin A in cellular models of cystic fibrosis inflammation. Inflamm (Lond). 2009;6:15.
48. Borsello T, Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des. 2007;13:1875-86.
49. Jang S, Kelley KW, Johnson RW. Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A. 2008;105:7534-9.
50. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805-20.
51. Fujioka S, Niu J, Schmidt C, Sclabas GM, Peng B, Uwagawa T, et al. NF-kB and AP-1 connection: mechanism of NF-kB-dependent regulation of AP-1 activity. Mol Cell Biol. 2004;24:7806-19.
52. Kang G, Kong PJ, Yuh YJ, Lim SY, Yim SV, Chun W, et al. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor. kappa. b bindings in BV2 microglial cells. J Pharmacol Sci. 2004;94:325-8.
53. Yang X, Du L, Tang X, Jung SY, Zheng B, Soh BY, et al. Brevicompanine E reduces lipopolysaccharide-induced production of proinflammatory cytokines and enzymes in microglia by inhibiting activation of activator protein-1 and nuclear factor-kB. J Neuroimmunol. 2009;216:32-8.
54. Yuan L, Wu Y, Ren X, Liu Q, Wang J, Liu X. Isoorientin attenuates lipopolysaccharide-induced pro-inflammatory responses through down-regulation of ROS-related MAPK/NF-kB signaling pathway in BV-2 microglia. Mol Cell Biochem. 2014;386:153-65.
55. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655-7.
56. Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 2003;24:358-63.
57. De Oliveira AC, Candelario-Jalil E, Langbein J, Wendeburg L, Bhatia HS, Schlachetzki JC, et al. Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia. J Neuroinflammation. 2012. doi: 10.1186/1742-2094-9-2.
58. Huttmann K, Sadgrove M, Wallraff A, Hinterkeuser S, Kirchhoff F, Steinhauser C, et al. Seizures preferentially stimulate proliferation of radial glia like astrocytes in the adult dentate gyrus: functional and immunocytochemical analysis. Eur J Neurosci. 2003;18:2769-78.
59. Karlstetter M, Lippe E, Walczak Y, Moehle C, Aslanidis A, Mirza M, et al. Curcumin is a potent modulator of microglial gene expression and migration. J Neuroinflammation. 2011;8:125.
60. Drache B, Diehl GE, Beyreuther K, Perlmutter LS, Konig G. Bcl xl Specific antibody labels activated microglia associated with Alzheimer's disease and other pathological states. J Neurosci Res. 1997;47:98-108.
61. Elsisi NS, Darling-Reed S, Lee EY, Oriaku ET, Soliman KF. Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia. Neurosci Lett. 2005;375:91-6.
62. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39:279-91.
63. Lively S, Schlichter LC. The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J Neuroinflammation. 2013;10:1186.